These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36100687)

  • 21. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients.
    Melcangi RC; Santi D; Spezzano R; Grimoldi M; Tabacchi T; Fusco ML; Diviccaro S; Giatti S; Carrà G; Caruso D; Simoni M; Cavaletti G
    J Steroid Biochem Mol Biol; 2017 Jul; 171():229-235. PubMed ID: 28408350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects.
    Irwig MS
    J Clin Psychiatry; 2012 Sep; 73(9):1220-3. PubMed ID: 22939118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.
    Chiriacò G; Cauci S; Mazzon G; Trombetta C
    Andrology; 2016 Mar; 4(2):245-50. PubMed ID: 26763726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia.
    Di Loreto C; La Marra F; Mazzon G; Belgrano E; Trombetta C; Cauci S
    PLoS One; 2014; 9(6):e100237. PubMed ID: 24959691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
    Ganzer CA; Jacobs AR; Iqbal F
    Am J Mens Health; 2015 May; 9(3):222-8. PubMed ID: 24928450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness.
    Motofei IG; Rowland DL; Georgescu SR; Baconi DL; Dimcevici NP; Paunica S; Constantin VD; Balalau C
    BJU Int; 2013 Apr; 111(4 Pt B):E221-6. PubMed ID: 23157321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate, baldness drugs linked to sexual dysfunction.
    Kuehn BM
    JAMA; 2012 May; 307(18):1903. PubMed ID: 22570451
    [No Abstract]   [Full Text] [Related]  

  • 28. 5-alpha reductase inhibitors and erectile dysfunction: the connection.
    Erdemir F; Harbin A; Hellstrom WJ
    J Sex Med; 2008 Dec; 5(12):2917-24. PubMed ID: 19090946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines on the use of finasteride in androgenetic alopecia.
    Mysore V; Shashikumar BM
    Indian J Dermatol Venereol Leprol; 2016; 82(2):128-34. PubMed ID: 26924401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
    Wu M; Yu Q; Li Q
    Oncotarget; 2016 Dec; 7(50):82074-82084. PubMed ID: 27738338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.
    Gur S; Kadowitz PJ; Hellstrom WJ
    Expert Opin Drug Saf; 2013 Jan; 12(1):81-90. PubMed ID: 23173718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia.
    Tosti A; Piraccini BM; Soli M
    J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):418-21. PubMed ID: 11763381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-finasteride syndrome.
    Pereira AFJR; Coelho TOA
    An Bras Dermatol; 2020; 95(3):271-277. PubMed ID: 32317131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
    Arias-Santiago S; Camacho-Martínez FM
    Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistent sexual side effects of finasteride: could they be permanent?
    Irwig MS
    J Sex Med; 2012 Nov; 9(11):2927-32. PubMed ID: 22789024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propecia lawsuits: the lasting effects of delayed drug warnings.
    Collier R
    CMAJ; 2013 Jul; 185(10):E455-6. PubMed ID: 23713074
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
    Corona G; Rastrelli G; Maseroli E; Balercia G; Sforza A; Forti G; Mannucci E; Maggi M
    J Endocrinol Invest; 2012 Nov; 35(10):915-20. PubMed ID: 22777612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of sexual function with an international index of erectile function in subjects taking finasteride for androgenetic alopecia.
    Tosti A; Pazzaglia M; Soli M; Rossi A; Rebora A; Atzori L; Barbareschi M; Benci M; Voudouris S; Vena GA
    Arch Dermatol; 2004 Jul; 140(7):857-8. PubMed ID: 15262698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of the federal adverse events reporting system data on adverse effects of 5-alpha reductase inhibitors.
    Harrell MB; Ho K; Te AE; Kaplan SA; Chughtai B
    World J Urol; 2021 Apr; 39(4):1233-1239. PubMed ID: 32596745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men.
    Irwig MS
    Sex Med Rev; 2014 Jan; 2(1):24-35. PubMed ID: 27784541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.